MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7435-7442

  Qing Yuan, Zhu ^a,b   Qin, Liu ^c   Jian Xia, Chen ^a   Ke, Lan ^a   Bao Xue, Ge ^a,c  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; DEXAMETHASONE; JANUS KINASE; LIGAND; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 101; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDOGLYCAN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNE RESPONSE; IMMUNOREGULATION; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DEXAMETHASONE; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE 4; MICE; MICRORNAS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TOLL-LIKE RECEPTORS;

EID: 78650643190     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000798     Document Type: Article

References (58)

1. Palm, N. W., and R. Medzhitov. 2009. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 227:221-233.
2. Takeuchi, O., and S. Akira. 2009. Innate immunity to virus infection. Immunol. Rev. 227:75-86.
3. Beutler, B. A. 2009. TLRs and innate immunity. Blood 113:1399-1407.
4. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
5. Nishida, E., and Y. Gotoh. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18:128-131. (Pubitemid 23105313)
6. Su, B., and M. Karin. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8:402-411.
7. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55-72.
8. Zarubin, T., and J. Han. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11-18.
9. Keyse, S. M. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192.
10. Owens, D. M., and S. M. Keyse. 2007. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26:3203-3213.
11. Liu, Y., E. G. Shepherd, and L. D. Nelin. 2007. MAPK phosphatases- regulating the immune response. Nat. Rev. Immunol. 7:202-212.
12. Wu, J. J., L. Zhang, and A. M. Bennett. 2005. The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation. Mol. Cell. Biol. 25:4792-4803.
13. Franklin, C. C., and A. S. Kraft. 1997. Conditional expression of the mitogenactivated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272:16917-16923.
14. Salojin, K. V., I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176:1899-1907.
15. Hammer, M., J. Mages, H. Dietrich, A. Servatius, N. Howells, A. C. Cato, and R. Lang. 2006. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203:15-20.
16. Chi, H., S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones, A. M. Bennett, and R. A. Flavell. 2006. Dynamic regulation of pro-and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA 103:2274-2279.
17. Zhao, Q., X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203:131-140.
18. Sánchez-Tilló, E., M. Comalada, C. Farrera, A. F. Valledor, J. Lloberas, and A. Celada. 2006. Macrophage-colony-stimulating factor-induced proliferation and lipopolysaccharide-dependent activation of macrophages requires Raf-1 phosphorylation to induce mitogen kinase phosphatase-1 expression. J. Immunol. 176:6594-6602.
19. Valledor, A. F., J. Xaus, M. Comalada, C. Soler, and A. Celada. 2000. Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 164:29-37.
20. Sánchez-Tilló, E., M. Comalada, J. Xaus, C. Farrera, A. F. Valledor, C. Caelles, J. Lloberas, and A. Celada. 2007. JNK1 Is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharidedependent activation. J. Biol. Chem. 282:12566-12573.
21. Hu, J. H., T. Chen, Z. H. Zhuang, L. Kong, M. C. Yu, Y. Liu, J. W. Zang, and B. X. Ge. 2007. Feedback control of MKP-1 expression by p38. Cell. Signal. 19:393-400.
22. Ambros, V. 2004. The functions of animal microRNAs. Nature 431:350-355.
23. Shyu, A. B., M. F. Wilkinson, and A. van Hoof. 2008. Messenger RNA regulation: to translate or to degrade. EMBO J. 27:471-481.
24. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
25. Liu, J. 2008. Control of protein synthesis and mRNA degradation by micro-RNAs. Curr. Opin. Cell Biol. 20:214-221.
26. Filipowicz, W., S. N. Bhattacharyya, and N. Sonenberg. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9:102-114.
27. Rajewsky, N. 2006. microRNA target predictions in animals. Nat. Genet. 38 (Suppl.): S8-S13.
28. O'Connell, R. M., A. A. Chaudhuri, D. S. Rao, and D. Baltimore. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106:7113-7118.
29. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103:12481-12486.
30. Sheedy, F. J., and L. A. O'Neill. 2008. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann. Rheum. Dis. 67 (Suppl. 3): iii50-iii55.
31. O'Connell, R. M., K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104:1604-1609.
32. Tili, E., J. J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru, B. Adair, M. Fabbri, H. Alder, C. G. Liu, G. A. Calin, and C. M. Croce. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179:5082-5089.
33. Falcone, D. J., and M. J. Ferenc. 1988. Acetyl-LDL stimulates macrophagedependent plasminogen activation and degradation of extracellular matrix. J. Cell. Physiol. 135:387-396.
34. Griffiths-Jones, S. 2006. miRBase: the microRNA sequence database. Methods Mol. Biol. 342:129-138.
35. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
36. Croce, C. M. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10:704-714.
37. John, B., C. Sander, and D. S. Marks. 2006. Prediction of human microRNA targets. Methods Mol. Biol. 342:101-113.
38. Wang, X., and Y. Liu. 2007. Regulation of innate immune response by MAP kinase phosphatase-1. Cell. Signal. 19:1372-1382.
39. Barnes, P. J. 2008. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8:183-192.
40. Cook, D. N., D. S. Pisetsky, and D. A. Schwartz. 2004. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5:975-979.
41. Kuwano, Y., H. H. Kim, K. Abdelmohsen, R. Pullmann, Jr., J. L. Martindale, X. L. Yang, and M. Gorospe. 2008. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol. Cell. Biol. 28:4562-4575.
42. An, H. X., A. Claas, L. Savelyeva, S. Seitz, P. Schlag, S. Scherneck, and M. Schwab. 1999. Two regions of deletion in 9p23-24 in sporadic breast cancer. Cancer Res. 59:3941-3943.
43. Ragnarsson, G., G. Eiriksdottir, J. T. Johannsdottir, J. G. Jonasson, V. Egilsson, and S. Ingvarsson. 1999. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br. J. Cancer 79:1468-1474.
44. Varambally, S., Q. Cao, R. S. Mani, S. Shankar, X. Wang, B. Ateeq, B. Laxman, X. Cao, X. Jing, K. Ramnarayanan, et al. 2008. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322:1695-1699.
45. Strillacci, A., C. Griffoni, P. Sansone, P. Paterini, G. Piazzi, G. Lazzarini, E. Spisni, M. A. Pantaleo, G. Biasco, and V. Tomasi. 2009. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp. Cell Res. 315:1439-1447.
46. Lee, Y., R. C. Samaco, J. R. Gatchel, C. Thaller, H. T. Orr, and H. Y. Zoghbi. 2008. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat. Neurosci. 11:1137-1139.
47. Wang, F. Z., F. Weber, C. Croce, C. G. Liu, X. Liao, and P. E. Pellett. 2008. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J. Virol. 82:9065-9074.
48. Boutros, T., A. Nantel, A. Emadali, G. Tzimas, S. Conzen, E. Chevet, and P. P. Metrakos. 2008. The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human liver response to transplantation. Am. J. Transplant. 8:2558-2568.
49. Fukao, T., and S. Koyasu. 2003. PI3K and negative regulation of TLR signaling. Trends Immunol. 24:358-363.
50. Fukao, T., M. Tanabe, Y. Terauchi, T. Ota, S. Matsuda, T. Asano, T. Kadowaki, T. Takeuchi, and S. Koyasu. 2002. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3:875-881.
51. Kim, A. H., G. Khursigara, X. Sun, T. F. Franke, and M. V. Chao. 2001. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase1. Mol. Cell. Biol. 21:893-901.
52. Gratton, J. P., M. Morales-Ruiz, Y. Kureishi, D. Fulton, K. Walsh, and W. C. Sessa. 2001. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J. Biol. Chem. 276:30359-30365.
53. Guha, M., and N. Mackman. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:32124-32132.
54. Sanchez, J. F., L. F. Sniderhan, A. L. Williamson, S. S. Fan, S. Chakraborty-Sett, and S. B. Maggirwar. 2003. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling. Mol. Cell. Biol. 23:4649-4662.
55. Okugawa, S., Y. Ota, T. Kitazawa, K. Nakayama, S. Yanagimoto, K. Tsukada, M. Kawada, and S. Kimura. 2003. Janus kinase 2 is involved in lipopolysaccharideinduced activation of macrophages. Am. J. Physiol. Cell Physiol. 285: C399-C408.
56. Leelawat, K., W. Udomchaiprasertkul, S. Narong, and S. Leelawat. 2010. Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells. J. Cancer Res. Clin. Oncol. 136:1537-1544.
57. Androulidaki, A., D. Iliopoulos, A. Arranz, C. Doxaki, S. Schworer, V. Zacharioudaki, A. N. Margioris, P. N. Tsichlis, and C. Tsatsanis. 2009. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31:220-231.
58. Arancibia, S., D. Benítez, L. E. Núñez, C. M. Jewell, P. Langjhar, E. Candia, G. Zapata-Torres, J. A. Cidlowski, M. J. González, and M. A. Hermoso. 2009. Phosphatidylinositol 3-kinase interacts with the glucocorticoid receptor upon TLR2 activation. J. Cell. Mol. Med. In press.